Clopimozide

TargetMol
Product Code: TAR-T25263
Supplier: TargetMol
CodeSizePrice
TAR-T25263-1mg1mg£185.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T25263-5mg5mg£360.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T25263-1mL1 mL * 10 mM (in DMSO)£423.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T25263-10mg10mg£496.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T25263-25mg25mg£760.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T25263-50mg50mg£1,018.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T25263-100mg100mg£1,348.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T25263-500mg500mg£2,633.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Clopimozide is a diphenylbutylpiperidine neuroleptic. It is mainly ataraxic and antidelusional, long-acting and accompanied with minimal side-effects.
CAS:
53179-12-7
Formula:
C28H28ClF2N3O
Molecular Weight:
496
Pathway:
Membrane transporter/Ion channel|Metabolism
Purity:
0.98
SMILES:
Fc1ccc(cc1)C(CCCN1CCC(CC1)n1c2ccc(Cl)cc2[nH]c1=O)c1ccc(F)cc1
Target:
Calcium Channel

References

1. De Cuyper HJ, Van Praag HM, Mulder WR. Therapeutical significance of clopimozide in the treatment of chronic psychotic patients. Acta Psychiatr Scand. 1979 May;59(5):561-74. PubMed PMID: 37697. 2. Janssen PA, Niemegeers CJ, Schellekens KH, Lenaerts FM, Wauquier A. Clopimozide (R 29 764), a new highly potent and orally long-acting neuroleptic of the diphenylbutylpiperidine series. Arzneimittelforschung. 1975 Aug;25(8):1287-94. PubMed PMID: 1242360. 3. Floru L, Tegeler J. Clinical experiments with the new oral long-acting neuroleptic clopimozide (R 29 764). Arzneimittelforschung. 1978;28(2):341-4. PubMed PMID: 25071. 4. Knapen J, Bollen J, Brugmanns J, Rombaut N. [Treatment of chronic psychoses with oral clopimozide]. Acta Psychiatr Belg. 1976 Jul-Aug;76(4):644-57. French. PubMed PMID: 798469.